vs
Side-by-side financial comparison of Monster Beverage (MNST) and Vertex Pharmaceuticals (VRTX). Click either name above to swap in a different company.
Vertex Pharmaceuticals is the larger business by last-quarter revenue ($3.2B vs $2.1B, roughly 1.5× Monster Beverage). Vertex Pharmaceuticals runs the higher net margin — 37.3% vs 21.1%, a 16.3% gap on every dollar of revenue. On growth, Monster Beverage posted the faster year-over-year revenue change (17.6% vs 9.5%). Monster Beverage produced more free cash flow last quarter ($351.2M vs $348.6M). Over the past eight quarters, Vertex Pharmaceuticals's revenue compounded faster (8.9% CAGR vs 5.9%).
Monster Beverage Corporation is an American beverage company that manufactures energy drinks including Monster Energy, Relentless, Reign and Burn. The company was originally founded as Hansen's in 1935 in Southern California, originally selling juice products. The company renamed itself as Monster Beverage in 2012.
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
MNST vs VRTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.1B | $3.2B |
| Net Profit | $449.2M | $1.2B |
| Gross Margin | 55.5% | 85.4% |
| Operating Margin | 25.5% | 37.8% |
| Net Margin | 21.1% | 37.3% |
| Revenue YoY | 17.6% | 9.5% |
| Net Profit YoY | 65.9% | 30.5% |
| EPS (diluted) | — | $4.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.1B | $3.2B | ||
| Q3 25 | $2.2B | $3.1B | ||
| Q2 25 | $2.1B | $3.0B | ||
| Q1 25 | $1.9B | $2.8B | ||
| Q4 24 | $1.8B | $2.9B | ||
| Q3 24 | $1.9B | $2.8B | ||
| Q2 24 | $1.9B | $2.6B | ||
| Q1 24 | $1.9B | $2.7B |
| Q4 25 | $449.2M | $1.2B | ||
| Q3 25 | $524.5M | $1.1B | ||
| Q2 25 | $488.8M | $1.0B | ||
| Q1 25 | $443.0M | $646.3M | ||
| Q4 24 | $270.7M | $913.0M | ||
| Q3 24 | $370.9M | $1.0B | ||
| Q2 24 | $425.4M | $-3.6B | ||
| Q1 24 | $442.0M | $1.1B |
| Q4 25 | 55.5% | 85.4% | ||
| Q3 25 | 55.7% | 86.5% | ||
| Q2 25 | 55.7% | 86.3% | ||
| Q1 25 | 56.5% | 86.9% | ||
| Q4 24 | 55.3% | 85.5% | ||
| Q3 24 | 53.2% | 85.8% | ||
| Q2 24 | 53.6% | 85.9% | ||
| Q1 24 | 54.1% | 87.3% |
| Q4 25 | 25.5% | 37.8% | ||
| Q3 25 | 30.7% | 38.6% | ||
| Q2 25 | 29.9% | 38.8% | ||
| Q1 25 | 30.7% | 22.7% | ||
| Q4 24 | 21.0% | 35.2% | ||
| Q3 24 | 25.5% | 40.3% | ||
| Q2 24 | 27.7% | -132.9% | ||
| Q1 24 | 28.5% | 42.4% |
| Q4 25 | 21.1% | 37.3% | ||
| Q3 25 | 23.9% | 35.2% | ||
| Q2 25 | 23.1% | 34.8% | ||
| Q1 25 | 23.9% | 23.3% | ||
| Q4 24 | 14.9% | 31.4% | ||
| Q3 24 | 19.7% | 37.7% | ||
| Q2 24 | 22.4% | -135.8% | ||
| Q1 24 | 23.3% | 40.9% |
| Q4 25 | — | $4.64 | ||
| Q3 25 | — | $4.20 | ||
| Q2 25 | — | $3.99 | ||
| Q1 25 | — | $2.49 | ||
| Q4 24 | — | $3.62 | ||
| Q3 24 | — | $4.01 | ||
| Q2 24 | — | $-13.92 | ||
| Q1 24 | — | $4.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.8B | $6.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.3B | $18.7B |
| Total Assets | $10.0B | $25.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.8B | $6.6B | ||
| Q3 25 | $2.6B | $6.3B | ||
| Q2 25 | $2.1B | $6.4B | ||
| Q1 25 | $1.9B | $6.2B | ||
| Q4 24 | $1.5B | $6.1B | ||
| Q3 24 | $1.6B | $6.5B | ||
| Q2 24 | $1.6B | $5.8B | ||
| Q1 24 | $3.6B | $10.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $199.1M | — | ||
| Q4 24 | $374.0M | — | ||
| Q3 24 | $748.8M | — | ||
| Q2 24 | $748.7M | — | ||
| Q1 24 | — | — |
| Q4 25 | $8.3B | $18.7B | ||
| Q3 25 | $7.7B | $17.3B | ||
| Q2 25 | $7.2B | $17.2B | ||
| Q1 25 | $6.5B | $16.5B | ||
| Q4 24 | $6.0B | $16.4B | ||
| Q3 24 | $5.8B | $15.6B | ||
| Q2 24 | $5.9B | $14.8B | ||
| Q1 24 | $8.6B | $18.5B |
| Q4 25 | $10.0B | $25.6B | ||
| Q3 25 | $9.6B | $24.9B | ||
| Q2 25 | $8.7B | $24.0B | ||
| Q1 25 | $8.2B | $22.9B | ||
| Q4 24 | $7.7B | $22.5B | ||
| Q3 24 | $8.1B | $22.2B | ||
| Q2 24 | $8.1B | $20.1B | ||
| Q1 24 | $10.1B | $23.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $379.4M | $498.0M |
| Free Cash FlowOCF − Capex | $351.2M | $348.6M |
| FCF MarginFCF / Revenue | 16.5% | 10.9% |
| Capex IntensityCapex / Revenue | 1.3% | 4.7% |
| Cash ConversionOCF / Net Profit | 0.84× | 0.42× |
| TTM Free Cash FlowTrailing 4 quarters | $2.0B | $3.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $379.4M | $498.0M | ||
| Q3 25 | $745.1M | $1.2B | ||
| Q2 25 | $466.0M | $1.1B | ||
| Q1 25 | $507.6M | $818.9M | ||
| Q4 24 | $461.7M | $584.6M | ||
| Q3 24 | $618.4M | $1.4B | ||
| Q2 24 | $436.3M | $-3.8B | ||
| Q1 24 | $412.1M | $1.3B |
| Q4 25 | $351.2M | $348.6M | ||
| Q3 25 | $701.5M | $1.1B | ||
| Q2 25 | $434.6M | $927.4M | ||
| Q1 25 | $478.5M | $778.2M | ||
| Q4 24 | $370.4M | $492.0M | ||
| Q3 24 | $571.4M | $1.3B | ||
| Q2 24 | $376.5M | $-3.8B | ||
| Q1 24 | $346.1M | $1.2B |
| Q4 25 | 16.5% | 10.9% | ||
| Q3 25 | 31.9% | 37.0% | ||
| Q2 25 | 20.6% | 31.3% | ||
| Q1 25 | 25.8% | 28.1% | ||
| Q4 24 | 20.4% | 16.9% | ||
| Q3 24 | 30.4% | 47.0% | ||
| Q2 24 | 19.8% | -144.5% | ||
| Q1 24 | 18.2% | 46.0% |
| Q4 25 | 1.3% | 4.7% | ||
| Q3 25 | 2.0% | 3.3% | ||
| Q2 25 | 1.5% | 4.9% | ||
| Q1 25 | 1.6% | 1.5% | ||
| Q4 24 | 5.0% | 3.2% | ||
| Q3 24 | 2.5% | 2.4% | ||
| Q2 24 | 3.1% | 2.6% | ||
| Q1 24 | 3.5% | 2.5% |
| Q4 25 | 0.84× | 0.42× | ||
| Q3 25 | 1.42× | 1.15× | ||
| Q2 25 | 0.95× | 1.04× | ||
| Q1 25 | 1.15× | 1.27× | ||
| Q4 24 | 1.71× | 0.64× | ||
| Q3 24 | 1.67× | 1.31× | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | 0.93× | 1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MNST
| Monster Energy Drinks Segment | $1.2B | 57% |
| Sales Revenue Product Line | $905.5M | 42% |
| Strategic Brands Segment | $50.3M | 2% |
| Alcohol Brands Segment | $29.0M | 1% |
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |
